Nuformix (FRA:1RT) Days Payable: 0.00 (As of Mar. 2026)


What is Nuformix Days Payable?

Nuformix FRA:1RT Days Payable is 0.00 as of Mar. 2026. The stock has 1 warning sign investors should review. Among 705 Biotechnology companies, Nuformix ranks worse than 141843.83% on this metric.

Nuformix's average Accounts Payable for the six months ended in Mar. 2026 was €0.16 Mil. Nuformix's Cost of Goods Sold for the six months ended in Mar. 2026 was €0.00 Mil.

The historical rank and industry rank for Nuformix's Days Payable or its related term are showing as below:

During the past 10 years, Nuformix's highest Days Payable was 10128.75. The lowest was 139.76. And the median was 247.52.

FRA:1RT's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.36
* Ranked among companies with meaningful Days Payable only.

Nuformix's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Nuformix Days Payable Historical Data

* Premium members only.

The historical data trend for Nuformix's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuformix Days Payable Chart

Nuformix Annual Data
Trend Dec15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Sep24 Sep25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 655.00 7,847.50 0.00 0.00 0.00

Nuformix Semi-Annual Data
Dec15 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:1RT vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Nuformix's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuformix Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuformix's Days Payable distribution charts can be found below:

* The bar in red indicates where Nuformix's Days Payable falls into.


Nuformix Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Nuformix's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as

Days Payable (A: Sep. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Sep. 2024 ) + Accounts Payable (A: Sep. 2025 )) / count ) / Cost of Goods Sold (A: Sep. 2025 )*Days in Period
=( (0.039 + 0.053) / 2 ) / 0*365
=0.046 / 0*365
=N/A

Nuformix's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0.053 + 0.262) / 2 ) / 0*365 / 2
=0.1575 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Nuformix (FRA:1RT) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nuformix and its competitors. Over the past decade, Nuformix's Days Payable has ranged from 139.76 to 10,128.75. According to the industry distribution chart, Nuformix ranks #999999 out of 705 companies in the Biotechnology industry.
Is Nuformix's Days Payable too high?
Nuformix's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 139.76 to a high of 10,128.75. Based on the distribution chart, Nuformix ranks #999999 out of 705 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Nuformix's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nuformix ranks #999999 out of 705 companies for Days Payable. This places Nuformix in the lower half of its industry. The industry median Days Payable is 113.36. Historically, Nuformix's own Days Payable has ranged from 139.76 to 10,128.75 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nuformix and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nuformix's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuformix stock overvalued right now?
Nuformix (FRA:1RT) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Nuformix (FRA:1RT), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nuformix Business Description

Other Exchanges NFX:UK1RT:Germany
Address C/O Arch Law Limited, 8 Bishopsgate, Huckletree Bishopsgate, London, GBR, EC2N 4BQ
Nuformix PLC is a pharmaceutical development company. It operates in pharmaceutical development, targeting unmet medical needs in fibrosis and oncology through drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.